1
Clinical Trials associated with 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine(Jiangsu Kunli Biomedicine)评价13价肺炎球菌多糖结合疫苗在2月龄(最小满6周龄)及以上健康人群中接种的安全性、耐受性和初步探索免疫原性的Ⅰ期临床试验
[Translation] A phase I clinical trial to evaluate the safety, tolerability and preliminary exploration of immunogenicity of 13-valent pneumococcal polysaccharide conjugate vaccine in healthy people aged 2 months (minimum 6 weeks) and above
评价13价肺炎球菌多糖结合疫苗在2月龄(最小满6周龄)及以上健康人群中的安全性、耐受性和初步探索免疫原性。
[Translation] To evaluate the safety, tolerability and preliminary immunogenicity of 13-valent pneumococcal polysaccharide conjugate vaccine in healthy people aged 2 months (minimum 6 weeks) and above.
100 Clinical Results associated with 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine(Jiangsu Kunli Biomedicine)
100 Translational Medicine associated with 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine(Jiangsu Kunli Biomedicine)
100 Patents (Medical) associated with 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine(Jiangsu Kunli Biomedicine)
100 Deals associated with 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine(Jiangsu Kunli Biomedicine)